ISPOR - Does the use of a surrogate outcome in solid state oncology htas decrease the chances of positive recommendations?

Full Text

Does the use of a surrogate outcome in solid state oncology htas decrease the chances of positive recommendations?

Abstract

Authors

A. Jaksa Y.S. Ho E. Rubinstein K. Daniel

Back to Volume 17, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now